ClinicalTrials.Veeva

Menu
C

Clinical Research Atlanta | Stockbridge, GA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

HFA
LY3502970
Eloralintide
Orforglipron
Ciclesonide Hydrofluoroalkane
Bococizumab
fluticasone propionate
Atogepant
Lubiprostone
Ciclesonide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 121 total trials

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes (ENLIGHTEN-1)

The purpose of this study is to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight who do not have type 2 diabetes...

Enrolling
Overweight
Obesity
Drug: Placebo
Drug: Eloralintide

The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo in participants with persistent obesity o...

Enrolling
Overweight
Obesity
Drug: Placebo
Drug: Eloralintide

The purpose of this study is to investigate the efficacy and safety of eloralintide and tirzepatide coformulation (EloraTZP) compared with tirzepatid...

Begins enrollment in 1 month
Obesity
Drug: Tirzepatide
Drug: Eloralintide

This study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weig...

Active, not recruiting
Overweight and/or Obesity
Nutrition Disorders
Drug: PF-08653944
Drug: PF-08653945

The purpose of this study is to provide safety data and demonstrate lot consistency with the PG4 vaccine by evaluating the immunogenicity of 3 differ...

Enrolling
Pneumococcal Disease
Biological: PG4 Multivalent Vaccine
Biological: 20 Valent Pneumococcal Conjugate Vaccine (20vPnC)

The purpose of this study is to evaluate the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age wi...

Active, not recruiting
SARS-CoV-2
Biological: mRNA-1283
Biological: mRNA-1273
Locations recently updated

Approximately one billion cases of seasonal influenza occur annually. Of these, 3 to 5 million illnesses are severe and responsible for up to 650,000...

Enrolling
Influenza
Combination Product: MK-1406
Combination Product: Placebo

The purpose of this study is to learn about safety in participants taking the study vaccine (mRNA-based vaccine) and the ability of the study vaccine...

Enrolling
Healthy Adults
Biological: Vaccine Candidate #2
Biological: Vaccine Candidate #6

The purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstrual period (PMP) for intermitt...

Enrolling
Menstrual Migraine
Drug: Rimegepant
Drug: Placebo Comparator

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Active, not recruiting
Lower Respiratory Tract Illness
Biological: RSVpreF
Biological: Placebo

Trial sponsors

Pfizer logo
BioNTech logo
Lilly logo
R
Moderna logo
Sumitomo Pharma logo
Allergan logo
Meda Pharmaceuticals logo
Novavax logo
MedImmune logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems